Logo image of CHR.CA

CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis

Canada - TSX:CHR - CA17040T8885 - Common Stock

23.33 CAD
+0.51 (+2.23%)
Last: 11/7/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, CHR scores 4 out of 10 in our fundamental rating. CHR was compared to 7 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. CHR is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CHR was profitable.
In the past year CHR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CHR reported negative net income in multiple years.
Each year in the past 5 years CHR had a positive operating cash flow.
CHR.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

Looking at the Return On Assets, with a value of -1.91%, CHR is in line with its industry, outperforming 42.86% of the companies in the same industry.
With a Return On Equity value of -4.82%, CHR perfoms like the industry average, outperforming 57.14% of the companies in the same industry.
CHR has a Return On Invested Capital of 6.54%. This is amongst the best in the industry. CHR outperforms 100.00% of its industry peers.
CHR had an Average Return On Invested Capital over the past 3 years of 5.30%. This is in line with the industry average of 5.73%.
The last Return On Invested Capital (6.54%) for CHR is above the 3 year average (5.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROIC 6.54%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR.CA Yearly ROA, ROE, ROICCHR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

CHR has a Operating Margin of 6.87%. This is in the better half of the industry: CHR outperforms 71.43% of its industry peers.
CHR's Operating Margin has declined in the last couple of years.
The Gross Margin of CHR (65.48%) is better than 100.00% of its industry peers.
CHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.87%
PM (TTM) N/A
GM 65.48%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR.CA Yearly Profit, Operating, Gross MarginsCHR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

4

2. Health

2.1 Basic Checks

CHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CHR has been reduced compared to 1 year ago.
CHR has more shares outstanding than it did 5 years ago.
CHR has a better debt/assets ratio than last year.
CHR.CA Yearly Shares OutstandingCHR.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR.CA Yearly Total Debt VS Total AssetsCHR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.92, we must say that CHR is in the distress zone and has some risk of bankruptcy.
CHR has a Altman-Z score (0.92) which is comparable to the rest of the industry.
The Debt to FCF ratio of CHR is 7.89, which is on the high side as it means it would take CHR, 7.89 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 7.89, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CHR has a Debt/Equity ratio of 0.54. This is a neutral value indicating CHR is somewhat dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.54, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Altman-Z 0.92
ROIC/WACC0.77
WACC8.47%
CHR.CA Yearly LT Debt VS Equity VS FCFCHR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.14 indicates that CHR should not have too much problems paying its short term obligations.
CHR has a Current ratio (1.14) which is in line with its industry peers.
CHR has a Quick Ratio of 1.14. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.61, CHR perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.61
CHR.CA Yearly Current Assets VS Current LiabilitesCHR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 78.57% over the past year.
The earnings per share for CHR have been decreasing by -19.03% on average. This is quite bad
CHR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.36%.
Measured over the past years, CHR shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%

3.2 Future

Based on estimates for the next years, CHR will show a small growth in Earnings Per Share. The EPS will grow by 6.05% on average per year.
The Revenue is expected to decrease by -4.27% on average over the next years.
EPS Next Y55.58%
EPS Next 2Y13.32%
EPS Next 3Y6.05%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.78%
Revenue Next 3Y-4.27%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHR.CA Yearly Revenue VS EstimatesCHR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR.CA Yearly EPS VS EstimatesCHR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.37, which indicates a very decent valuation of CHR.
Based on the Price/Earnings ratio, CHR is valued cheaper than 100.00% of the companies in the same industry.
CHR is valuated cheaply when we compare the Price/Earnings ratio to 26.06, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 12.03, which indicates a correct valuation of CHR.
CHR's Price/Forward Earnings ratio is rather cheap when compared to the industry. CHR is cheaper than 85.71% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.73, CHR is valued rather cheaply.
Industry RankSector Rank
PE 10.37
Fwd PE 12.03
CHR.CA Price Earnings VS Forward Price EarningsCHR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHR is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CHR is valued a bit cheaper than the industry average as 71.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.21
EV/EBITDA 4.34
CHR.CA Per share dataCHR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.19
PEG (5Y)N/A
EPS Next 2Y13.32%
EPS Next 3Y6.05%

3

5. Dividend

5.1 Amount

CHR has a Yearly Dividend Yield of 1.40%. Purely for dividend investing, there may be better candidates out there.
CHR's Dividend Yield is comparable with the industry average which is at 2.45.
With a Dividend Yield of 1.40, CHR pays less dividend than the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 1.4%

5.2 History

On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
CHR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
CHR.CA Yearly Dividends per shareCHR.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2025 1 2 3

5.3 Sustainability

CHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CHR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-34.57%
EPS Next 2Y13.32%
EPS Next 3Y6.05%
CHR.CA Yearly Income VS Free CF VS DividendCHR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR (11/7/2025, 7:00:00 PM)

23.33

+0.51 (+2.23%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners3.2%
Inst Owner ChangeN/A
Ins Owners1.35%
Ins Owner ChangeN/A
Market Cap594.45M
Revenue(TTM)1.37B
Net Income(TTM)-25.87M
Analysts78
Price Target29.11 (24.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.4%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-34.57%
Div Incr Years0
Div Non Decr Years0
Ex-Date12-12 2025-12-12 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.45%
Min EPS beat(2)3.87%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)3.87%
Max EPS beat(4)207.96%
EPS beat(8)5
Avg EPS beat(8)11.1%
EPS beat(12)6
Avg EPS beat(12)4.98%
EPS beat(16)8
Avg EPS beat(16)3.11%
Revenue beat(2)0
Avg Revenue beat(2)-6.13%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-3.95%
Revenue beat(4)0
Avg Revenue beat(4)-6%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-2.48%
Revenue beat(12)5
Avg Revenue beat(12)-1.45%
Revenue beat(16)8
Avg Revenue beat(16)1.16%
PT rev (1m)1.78%
PT rev (3m)1.55%
EPS NQ rev (1m)-0.35%
EPS NQ rev (3m)-5.97%
EPS NY rev (1m)0.17%
EPS NY rev (3m)-4.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.42%
Valuation
Industry RankSector Rank
PE 10.37
Fwd PE 12.03
P/S 0.43
P/FCF 12.21
P/OCF 7.03
P/B 1.11
P/tB 1.13
EV/EBITDA 4.34
EPS(TTM)2.25
EY9.64%
EPS(NY)1.94
Fwd EY8.31%
FCF(TTM)1.91
FCFY8.19%
OCF(TTM)3.32
OCFY14.23%
SpS53.68
BVpS21.08
TBVpS20.74
PEG (NY)0.19
PEG (5Y)N/A
Graham Number32.67
Profitability
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROCE 8.82%
ROIC 6.54%
ROICexc 6.9%
ROICexgc 6.96%
OM 6.87%
PM (TTM) N/A
GM 65.48%
FCFM 3.56%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Debt/EBITDA 1.36
Cap/Depr 30.21%
Cap/Sales 2.62%
Interest Coverage 2.06
Cash Conversion 39.75%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.61
Altman-Z 0.92
F-Score5
WACC8.47%
ROIC/WACC0.77
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
EPS Next Y55.58%
EPS Next 2Y13.32%
EPS Next 3Y6.05%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%
Revenue Next Year-4.85%
Revenue Next 2Y-3.78%
Revenue Next 3Y-4.27%
Revenue Next 5YN/A
EBIT growth 1Y-53.02%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year86.18%
EBIT Next 3Y12.53%
EBIT Next 5YN/A
FCF growth 1Y-79.47%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-70.44%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR.CA FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 4 / 10 to CHR.CA.


What is the valuation status for CHR stock?

ChartMill assigns a valuation rating of 7 / 10 to CHORUS AVIATION INC (CHR.CA). This can be considered as Undervalued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR.CA) has a profitability rating of 5 / 10.


What are the PE and PB ratios of CHORUS AVIATION INC (CHR.CA) stock?

The Price/Earnings (PE) ratio for CHORUS AVIATION INC (CHR.CA) is 10.37 and the Price/Book (PB) ratio is 1.11.


What is the expected EPS growth for CHORUS AVIATION INC (CHR.CA) stock?

The Earnings per Share (EPS) of CHORUS AVIATION INC (CHR.CA) is expected to grow by 55.58% in the next year.